SEC-Pulse-blog-masthead

SEC Issues Concept Release on Harmonization of Securities Offering Exemptions

SEC Proposes Amendments to Accelerated and Large Accelerated Filer Definitions

SEC Proposes Changes to REG S-X

Simplification of FAST Act Disclosure Requirements

SEC Issues Concept Release about Quarterly Reporting

SEC Adopts Rules for Disclosure of Hedging Policies

ISS Annual Proxy Voting Updates

SEC amends Rule 701 and solicits comments on ways to modernize offerings pursuant to compensatory arrangements

SEC expands "smaller reporting company" definition

SEC Requires "Inline XBRL"

Form BE-12 – Affirmative BEA Reporting Obligation for Foreign Owned Entities

SEC issues guidance on cybersecurity disclosures

NYSE Rule Change: Material News at End of the Day

Simplification of Regulation S-K - Proposed Rules

Insider Trading and Equifax

SEC fees to increase on October 1st

Confidential IPO Filing System to be Expanded

Auditor Reports to Require Additional Information

Sullivan Advises Select Income REIT in Offering of $350 Million of Unsecured Notes

SEC Announces New Changes to Covers of Periodic Reports and Registration Statements

ZAG/Sullivan Represents Therapix Biosciences in $13.8 Million Initial Public Offering

SEC Adopts T+2 Settlement Cycle for Securities Transactions

SEC Approves Rules to Require Hyperlinks in Exhibit Lists

ZAG/Sullivan Represents Pluristem Therapeutics in $17.3 Million Stock Offering

Sullivan Advises Hospitality Properties Trust in Offering of $600 Million of Unsecured Notes

Fast-paced December for U.S.-Israeli Law Firm ZAG/Sullivan Representing Underwriters in Offerings

ZAG/Sullivan Advises in Rosetta Genomics' U.S. Offering

Change Regarding Mailing of Annual Reports to Stockholders

SEC Proposes "Universal" Proxy Card for Contested Elections

SEC Proposes T+2 for Settling Securities Transactions

ZAG/Sullivan Represents Nano Dimension Ltd in U.S. NASDAQ ADS Public Offering

ZAG/Sullivan Provides U.S. Legal Advice to Medigus Ltd. in Offering of ADSs

SEC proposes hyperlinks for filing exhibits

SEC Raises Fees for Issuers

ZAG/Sullivan Advises on Cellect Biotechnology U.S. IPO

Chipping away at disclosure overload

SEC Guidance on Reg G: Q&A with Howard Berkenblit

SEC Adopts Amendment to Form 10-K Implementing FAST Act Provision

Small Entity Compliance Guide for Issuers

Changes for Non-GAAP Measures in Earnings Releases

Be Careful What You Say – Or Rather What You Don’t Say – AVEO Pays $4 Million to SEC to Settle Fraud Charges

New SEC fee calculator!

First NASDAQ Listings by Israeli-based Companies in 2016

Newly Codified Exemption for Private Resales of Securities

Plain English Guidance for Crowdfunding

New SEC Rules re: Forms S-1 and F-1

Sullivan Client Advisory: FAST Act Legislation Eases Capital Raising Restrictions And Seeks To Simplify Disclosure Requirements

SEC issues staff report on accredited investor definition

Audit partner names to be made public

Crowdfunding – What You Need To Know

SEC adopts rules permitting crowdfunding

SEC registration fees to decrease on October 1st

Sullivan Client Advisory: New SEC Rule to Require Disclosure of Ratio of CEO Compensation to Median Worker Compensation

Reg D / general solicitation interpretations

SEC adopts rule for pay ratio disclosure

SEC proposes rules requiring companies to adopt clawback policies on executive compensation

SEC solicits public comment on audit committee disclosures

SEC no-review letters to be publicly available

SEC to propose rules re: relationship between executive comp and company performance

Sullivan Client Advisory: SEC Adopts “Regulation A+” Creating a New Category of Exempt Private Placements

Regulation "A+" adopted by SEC

SEC proposes rule re: disclosure in proxy statements of hedging policies

Sullivan 4c

About the Blog


The SEC Pulse provides updates and commentary from our Capital Markets Group on issues affecting publicly traded and privately owned businesses, investment banks and foreign companies who trade or raise capital in the United States, and boards of directors and company officers in securities transactions and corporate governance matters.

The material on this site is for general information only and is not legal advice. No liability is accepted for any loss or damage which may result from reliance on it. Always consult a qualified lawyer about a specific legal problem.

Subscribe to Blog

Recent Posts

Posts by Topic

see all